CCS/CHFS Heart Failure Guidelines Update: Defining a New Pharmacologic Standard of Care for Heart Failure With Reduced Ejection FractionMichael McDonald, Amelia Yip, Sean Virani et al.|Canadian Journal of Cardiology|2021Cited by 290
CCS/CHFS Heart Failure Guidelines: Clinical Trial Update on Functional Mitral Regurgitation, SGLT2 Inhibitors, ARNI in HFpEF, and Tafamidis in AmyloidosisEileen O’Meara, Bruce Sussex, Michael McDonald et al.|Canadian Journal of Cardiology|2020Cited by 121
Blinded Randomized Trial of Anticoagulation to Prevent Ischemic Stroke and Neurocognitive Impairment in Atrial Fibrillation (BRAIN-AF): Methods and DesignLéna Rivard, Denis Roy, Hélène Mayrand et al.|Canadian Journal of Cardiology|2019Cited by 40
The Status of Specialized Ambulatory Heart Failure Care in Canada: A Joint Canadian Heart Failure Society and Canadian Cardiovascular Society Heart Failure Guidelines SurveySean Virani, Bruce Sussex, Shelley Zieroth et al.|CJC Open|2020Cited by 18
Outcomes of Patients With ST-Elevation Myocardial Infarction Receiving and Not Receiving Reperfusion Therapy: The Importance of Examining All PatientsLaurie Lambert, Peter Bogaty, James M. Brophy et al.|Canadian Journal of Cardiology|2016Cited by 15